[1] Jacobs AH, Walton RG. The incidence of birthmarks in the neonate [J]. Pediatrics, 1976, 58(2): 218-222. [2] Pandey A, Gangopadhyay AN, Sharma SP, et al. Conservative management of ulcerated hemangioma-twenty years experience[J]. Int Wound J, 2009, 6(1): 59-62. [3] Maguiness SM, Hoffman WY, McCalmont TH, et al. Early white discoloration of infantile hemangioma: a sign of impending ulceration [J]. Arch Dermatol, 2010, 146 (11): 1235-1239. [4] Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children [J]. N Engl J Med, 1999, 341(3): 173-181. [5] Fost NC, Esterly NB. Successful treatment of juvenile hemangiomas with prednisone[J]. J Pediatr,1968,72(3):351-357. [6] Pandey A, Gangopadhuay AN, Gopal SC, et al. Twenty years' experience of steroids in infantile hemangioma a developing country′s perspective [J]. J Pediatr Surg, 2009, 44(4): 688-694. [7] 郑家伟, 王延安, 周国瑜, 等.头颈部血管瘤治疗适应证的探讨 [J]. 上海口腔医学, 2007, 16(4): 337-342. [8] Metry DW, Hebert AA. Benign cutaneous vascular tumors of infancy: when to worry, What to do[J]. Arch Dermatol,2000,136(7): 905-914. [9] Kim HJ, Colombo M, Frieden IJ. Ulcerated hemangiomas: clinical characteristics and response to therapy [J]. J Am Acad Dermatol, 2001, 44(6): 962-972. [10] 周国瑜, 沈玲悦, 田克斌, 等. 长脉冲可调脉宽Gentle YAG 1064 nm 激光治疗颌面部血管瘤113例效果评估 [J]. 上海口腔医学, 2006, 15(3): 250-253. [11] Kaune KM, Lauerer P, Kietz S, et al. Combination therapy of infantile hemangiomas with pulsed dye laser and Nd:YAG laser is effective and safe [J]. J Dtsch Dermatol Ges, 2014, 12(6): 473-478. [12] Capon A, Mordon S. Can thermal lasers promote skin wound Healing? [J]. Am J Clin Dermatol, 2003, 4(1): 1-12. [13] Ortiz AE, Ross EV. A complication of an eyelid hemangioma treated with a long-pulsed 1064 nm Nd:YAG laser [J].Lasers Surg Med, 2010, 42(10): 736-737. [14] Khan IS, Kiehna EN, Satti KF, et al. Surgical management of large scalp infantile hemangiomas[J]. Surg Neurol Int,2014,5: 41. [15] Greenberger S, Boscolo E, Adini I, et al. Corticosteroid suppression of VEG-F-A in infantile hemangioma derived stem cells [J]. N Eng Med, 2010,362(11):1005-1013. [16] Xu SQ, Jia RB, Zhang W, et al. Beta-blockers versus corticosteroids in the treatment of infantile hemangioma: an evidence-based systematic review[J]. World J Pediatr, 2013, 9(3): 221-229. [17] 郑家伟, 秦中平, 张志愿, 等. 口服皮质激素治疗婴幼儿口腔颌面部血管瘤 [J]. 中国口腔颌面外科杂志, 2006, 4(3): 228-232. [18] Laranjo S, Costa G, Paramés F, et al. The role of propranolol in the treatment of infantile hemangioma [J]. Rev Port Cardiol, 2014, 33(5): 289-295. [19] Hermans DJ, Bauland CG, Zweegers J, et al. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions [J]. Br J Dermatol, 2013, 168(4): 837-843. [20] Boye E, Jinnin M, Olsen BR. Infantile hemangioma: challenges, new insights, and therapeutic promise [J]. J Craniofac Surg, 2009, 20(Suppl 1): 678-684. [21] Pope E, Krafchik BR, Macarthur C, et al. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial [J]. Pediatrics, 2007, 119(6): e1239-1247. [22] Ho NT, Lansang P, Pope E. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study [J]. J Am Acad Dermatol, 2007, 56(1): 63-68. [23] Munden A, Butschek R, Tom WL, et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies [J]. Br J Dermatol, 2014, 170(4): 907-913. |